Those positive estimates also rest largely on the early-phase studies, and the single most heavily weighted Phase 3 result, the null Exenatide-PD3 trial, argues against a robust class-wide effect
Off-Label Promotion and Ethical Implications The aggressive marketing strategies employed to promote GLP-1 agonists for weight loss prior to obtaining formal regulatory approval for such indications raise significant ethical and legal questions
It functions as a potent activator of tissue remodeling via upregulation of collagen I, III, and IV synthesis, elastin production, glycosaminoglycan accumulation, and metalloproteinase modulation
Robert A Koeth, Zeneng Wang, Bruce S Levison, Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis, 2013 Judith L Flanagan, Peter A Simmons, Role of carnitine in disease, 2010 .
GHK-Cus legitimate regulatory home is as a cosmetic ingredient, a category that governs topical appearance claims, not medical efficacy